drugset / Trial / NCT00346866
Anecortave Acetate Versus Placebo in AMD Patients Following PDT
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study was to evaluate the efficacy of anecortave acetate for depot suspension (30 mg and 15 mg) plus PDT versus PDT alone with respect to maintenance of visual acuity in patients with wet AMD.
Timeline
- Start
- 2000-05
- Primary completion
- 2001-12
- Completion
- 2001-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anecortave Acetate | Small molecule | 15 mg | — |
| Subject | Anecortave Acetate | Small molecule | 30 mg | — |
Indications
No indication recorded.